{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:13:16Z","timestamp":1785129196958,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00432-021-03518-5","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:03:14Z","timestamp":1611151394000},"page":"1307-1313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-6284","authenticated-orcid":false,"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Badalamenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Teriaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mercante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Spriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"7","key":"3518_CR1","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/hed.25695","volume":"41","author":"JE Bates","year":"2019","unstructured":"Bates JE, De Leo AN, Morris CG, Amdur RJ, Dagan R (2019) Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: single-institution outcomes. Head Neck 41(7):2309\u20132314. https:\/\/doi.org\/10.1002\/hed.25695","journal-title":"Head Neck"},{"key":"3518_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2019.04.006","volume":"93","author":"P Bonomo","year":"2019","unstructured":"Bonomo P, Greto D, Desideri I et al (2019) Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? Oral Oncol 93:1\u20137. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.04.006","journal-title":"Oral Oncol"},{"issue":"10212","key":"3518_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet (Lond, Engl) 394(10212):1915\u20131928. https:\/\/doi.org\/10.1016\/S0140-6736(19)32591-7","journal-title":"Lancet (Lond, Engl)"},{"issue":"11","key":"3518_CR4","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1200\/JCO.2012.45.9651","volume":"31","author":"KS Corbin","year":"2013","unstructured":"Corbin KS, Hellman S, Weichselbaum RR (2013) Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol 31(11):1384\u20131390. https:\/\/doi.org\/10.1200\/JCO.2012.45.9651","journal-title":"J Clin Oncol"},{"issue":"2","key":"3518_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12325-018-0662-8","volume":"35","author":"R de Bree","year":"2018","unstructured":"de Bree R, Senft A, Coca-Pelaz A et al (2018) Detection of distant metastases in head and neck cancer: changing landscape. Adv Ther 35(2):161\u2013172. https:\/\/doi.org\/10.1007\/s12325-018-0662-8","journal-title":"Adv Ther"},{"key":"3518_CR6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713112","author":"W Dudek","year":"2020","unstructured":"Dudek W, AlMoussa E, Schreiner W, Mantsopoulos K, Sirbu H (2020) Survival and prognostic analysis after pulmonary metastasectomy for head and neck cancer. Thorac Cardiovasc Surg. https:\/\/doi.org\/10.1055\/s-0040-1713112","journal-title":"Thorac Cardiovasc Surg"},{"issue":"4","key":"3518_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000055740","volume":"63","author":"A Ferlito","year":"2001","unstructured":"Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V (2001) Incidence and sites of distant metastases from head and neck cancer. ORL 63(4):202\u2013207. https:\/\/doi.org\/10.1159\/000055740","journal-title":"ORL"},{"issue":"19","key":"3518_CR8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G, Fayette J et al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375(19):1856\u20131867. https:\/\/doi.org\/10.1056\/NEJMoa1602252","journal-title":"N Engl J Med"},{"issue":"1","key":"3518_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.critrevonc.2014.01.004","volume":"91","author":"C Florescu","year":"2014","unstructured":"Florescu C, Thariat J (2014) Local ablative treatments of oligometastases from head and neck carcinomas. Crit Rev Oncol Hematol 91(1):47\u201363. https:\/\/doi.org\/10.1016\/j.critrevonc.2014.01.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"3518_CR10","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1002\/cam4.1707","volume":"7","author":"C Franzese","year":"2018","unstructured":"Franzese C, Zucali PA, Di Brina L et al (2018) The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer. Cancer Med 7(9):4379\u20134386. https:\/\/doi.org\/10.1002\/cam4.1707","journal-title":"Cancer Med"},{"issue":"1","key":"3518_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.juro.2018.08.049","volume":"201","author":"C Franzese","year":"2019","unstructured":"Franzese C, Franceschini D, Di Brina L et al (2019) Role of stereotactic body radiation therapy for the management of oligometastatic renal cell carcinoma. J Urol 201(1):70\u201376. https:\/\/doi.org\/10.1016\/j.juro.2018.08.049","journal-title":"J Urol"},{"issue":"1","key":"3518_CR12","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18\u2013e28. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1","journal-title":"Lancet Oncol"},{"key":"3518_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8\u201310","journal-title":"J Clin Oncol"},{"key":"3518_CR14","first-page":"378","volume":"2011","author":"S Hellman","year":"2011","unstructured":"Hellman S, Weichselbaum RR (2011) Oligometastases revisited Page_5. Nat Rev Clin Oncol. 2011:378\u2013382","journal-title":"Nat Rev Clin Oncol."},{"issue":"4","key":"3518_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jamaoto.2016.3668","volume":"143","author":"A Hosni","year":"2017","unstructured":"Hosni A, Huang SH, Xu W et al (2017) Distant metastases following postoperative intensity-modulated radiotherapy for oral cavity squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 143(4):368\u2013375. https:\/\/doi.org\/10.1001\/jamaoto.2016.3668","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"3518_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11864-017-0484-y","volume":"18","author":"SH Huang","year":"2017","unstructured":"Huang SH, O\u2019Sullivan B (2017) Overview of the 8th edition classification for head and neck cancer. Curr Treat Options Oncol 18(7):40. https:\/\/doi.org\/10.1007\/s11864-017-0484-y","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"3518_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","volume":"3","author":"JE Leeman","year":"2017","unstructured":"Leeman JE, Li J, Pei X et al (2017) Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques. JAMA Oncol 3(11):1487. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0973","journal-title":"JAMA Oncol"},{"key":"3518_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","volume":"148","author":"Y Lievens","year":"2020","unstructured":"Lievens Y, Guckenberger M, Gomez D et al (2020) Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document. Radiother Oncol 148:157\u2013166. https:\/\/doi.org\/10.1016\/j.radonc.2020.04.003","journal-title":"Radiother Oncol"},{"issue":"1","key":"3518_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/COC.0b013e3181d26d45","volume":"34","author":"S Lloyd","year":"2011","unstructured":"Lloyd S, Yu JB, Wilson LD, Decker RH (2011) Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 34(1):76\u201381. https:\/\/doi.org\/10.1097\/COC.0b013e3181d26d45","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"3518_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000076905","volume":"27","author":"P-Y Marcy","year":"2004","unstructured":"Marcy P-Y, Magn\u00e9 N, Bailet C et al (2004) Liver metastases from head and neck squamous cell carcinomas: radiological and biological features. Onkologie 27(2):157\u2013160. https:\/\/doi.org\/10.1159\/000076905","journal-title":"Onkologie"},{"issue":"6","key":"3518_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.hoc.2015.07.008","volume":"29","author":"DN Margalit","year":"2015","unstructured":"Margalit DN, Schoenfeld JD, Tishler RB (2015) Radiation oncology\u2014new approaches in squamous cell cancer of the head and neck. Hematol Oncol Clin N Am 29(6):1093\u20131106. https:\/\/doi.org\/10.1016\/j.hoc.2015.07.008","journal-title":"Hematol Oncol Clin N Am"},{"key":"3518_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/cncr.23209","volume":"2007","author":"MT Milano","year":"2007","unstructured":"Milano MT, Katz AW, Muhs AG et al (2007) A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2007:650\u2013658. https:\/\/doi.org\/10.1002\/cncr.23209","journal-title":"Cancer"},{"issue":"5","key":"3518_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/ejcts\/ezy384","volume":"55","author":"T Oki","year":"2019","unstructured":"Oki T, Hishida T, Yoshida J et al (2019) Survival and prognostic factors after pulmonary metastasectomy of head and neck cancer: what are the clinically informative prognostic indicators? Eur J Cardiothorac Surg 55(5):942\u2013947. https:\/\/doi.org\/10.1093\/ejcts\/ezy384","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"3518_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/jjco\/hyw095","volume":"46","author":"M Ooishi","year":"2016","unstructured":"Ooishi M, Motegi A, Kawashima M et al (2016) Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer. Jpn J Clin Oncol 46(10):919\u2013927. https:\/\/doi.org\/10.1093\/jjco\/hyw095","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"3518_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/cancers11020133","volume":"11","author":"S Otake","year":"2019","unstructured":"Otake S, Goto T (2019) Stereotactic radiotherapy for oligometastasis. Cancers (Basel) 11(2):133. https:\/\/doi.org\/10.3390\/cancers11020133","journal-title":"Cancers (Basel)"},{"key":"3518_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26117","author":"D Pasalic","year":"2020","unstructured":"Pasalic D, Betancourt-Cuellar SL, Taku N et al (2020) Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck. https:\/\/doi.org\/10.1002\/hed.26117","journal-title":"Head Neck"},{"issue":"15_suppl","key":"3518_CR27","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1200\/JCO.2019.37.15_suppl.6000","volume":"37","author":"D Rischin","year":"2019","unstructured":"Rischin D, Harrington KJ, Greil R et al (2019) Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent\/metastatic head and neck squamous cell carcinoma (R\/M HNSCC). J Clin Oncol. 37(15_suppl):6000\u20136000. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.6000","journal-title":"J Clin Oncol."},{"issue":"1","key":"3518_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.radonc.2017.03.019","volume":"124","author":"CG Rusthoven","year":"2017","unstructured":"Rusthoven CG, Lanning RM, Jones BL et al (2017) Metastatic nasopharyngeal carcinoma: patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy. Radiother Oncol 124(1):139\u2013146. https:\/\/doi.org\/10.1016\/j.radonc.2017.03.019","journal-title":"Radiother Oncol"},{"issue":"29","key":"3518_CR29","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1200\/JCO.2015.62.0963","volume":"33","author":"AG Sacco","year":"2015","unstructured":"Sacco AG, Cohen EE (2015) Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol 33(29):3305\u20133313. https:\/\/doi.org\/10.1200\/JCO.2015.62.0963","journal-title":"J Clin Oncol"},{"issue":"5","key":"3518_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00405-018-4920-9","volume":"275","author":"D Schulz","year":"2018","unstructured":"Schulz D, Wirth M, Piontek G et al (2018a) Improved overall survival in head and neck cancer patients after specific therapy of distant metastases. Eur Arch Oto-Rhino-Laryngol 275(5):1239\u20131247. https:\/\/doi.org\/10.1007\/s00405-018-4920-9","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"5","key":"3518_CR31","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00405-018-4920-9","volume":"275","author":"D Schulz","year":"2018","unstructured":"Schulz D, Wirth M, Piontek G et al (2018b) Improved overall survival in head and neck cancer patients after specific therapy of distant metastases. Eur Arch Otorhinolaryngol 275(5):1239\u20131247. https:\/\/doi.org\/10.1007\/s00405-018-4920-9","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"3518_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13014-018-1185-9","volume":"13","author":"M Scorsetti","year":"2018","unstructured":"Scorsetti M, Comito T, Clerici E et al (2018) Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up. Radiat Oncol 13(1):234. https:\/\/doi.org\/10.1186\/s13014-018-1185-9","journal-title":"Radiat Oncol"},{"issue":"9","key":"3518_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/fon-2017-0468","volume":"14","author":"XS Sun","year":"2018","unstructured":"Sun XS, Michel C, Babin E et al (2018) Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC. Future Oncol 14(9):877\u2013889. https:\/\/doi.org\/10.2217\/fon-2017-0468","journal-title":"Future Oncol"},{"issue":"9","key":"3518_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.oraloncology.2012.03.013","volume":"48","author":"RP Takes","year":"2012","unstructured":"Takes RP, Rinaldo A, Silver CE et al (2012) Distant metastases from head and neck squamous cell carcinoma. Part I Basic aspects. Oral Oncol 48(9):775\u2013779. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.03.013","journal-title":"Oral Oncol"},{"key":"3518_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26144","author":"T Vengaloor Thomas","year":"2020","unstructured":"Vengaloor Thomas T, Packianathan S, Bhanat E et al (2020) Oligometastatic head and neck cancer: Comprehensive review. Head Neck. https:\/\/doi.org\/10.1002\/hed.26144","journal-title":"Head Neck"},{"issue":"11","key":"3518_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359(11):1116\u20131127. https:\/\/doi.org\/10.1056\/NEJMoa0802656","journal-title":"N Engl J Med"},{"key":"3518_CR37","doi-asserted-by":"publisher","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors. J Nucl Med. 2009;50(1):122S-150S. doi:https:\/\/doi.org\/10.2967\/jnumed.108.057307","DOI":"10.2967\/jnumed.108.057307"},{"issue":"3","key":"3518_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/coa.12348","volume":"40","author":"ER Young","year":"2015","unstructured":"Young ER, Diakos E, Khalid-Raja M, Mehanna H (2015) Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis. Clin Otolaryngol 40(3):208\u2013218. https:\/\/doi.org\/10.1111\/coa.12348","journal-title":"Clin Otolaryngol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03518-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03518-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03518-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T15:47:15Z","timestamp":1633103235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03518-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3518"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03518-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest disclosures from any authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}